Back

Dapagliflozin effect on cardiopulmonary function in HFrEF patients

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Effective treatment of heart failure Pharmacotherapy Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Massimo Mapelli

Monzino Cardiology Centre, Milan (Italy)

8 More presentations in this session

Presentation thumbnail
Long-term effects of exercise training in patients with heart failure with preserved ejection fraction - a follow-up study of two randomised controlled trials
Doctor S. Mueller Stegner (Munich, DE)
Abstract Slides
Presentation thumbnail
Effects of high-intensity interval training, moderate continuous training or usual care on ventilatory efficiency parameters in patients with heart failure with preserved ejection fraction
Doctor S. Mueller Stegner (Munich, DE)
Abstract Slides
Presentation thumbnail
Heart failure with preserved ejection fraction incidence in hypertensive patients according to cardiorespiratory fitness
Professor P. Kokkinos (Washington DC, US)
Abstract Slides
Presentation thumbnail
Effect of exercise training on cardiac reserve in heart failure with preserved ejection fraction: a substudy from OptimEx-CLIN
Assistant Professor A. Gevaert (Antwerp, BE)
Abstract Slides
Presentation thumbnail
Assessing malnutrition to prevent mortality in patients with advanced heart failure: Hades study
Doctor M. Munoz (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Effective treatment of heart failure

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources